You are here

Tarceva

Drug makers pay $67m for misleading docs about cancer drug survival data

Stat

Mon, 06/6/16 - 11:21 pm

OSI Pharmaceuticals

False Claims Act

whistleblower lawsuits

non-small cell lung cancer

Roche resolves patent war with India's Glenmark over generic Tarceva

Fierce Pharma

Mon, 01/4/16 - 10:44 pm

Opportunities in Lung Cancer Therapies

Motley Fool

Sun, 11/24/13 - 12:30 pm

non-small cell lung cancer

Array Biopharma

Clovis Oncology

Ariad Pharmaceuticals

Roche's Tarceva Progresses in Japan

Yahoo/Zacks

Tue, 06/18/13 - 08:59 am

non-small cell lung cancer

Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players

Motley Fool

Wed, 03/20/13 - 11:56 am

FDA fast tracks two new lung cancer drugs

PM Live

Fri, 01/18/13 - 10:17 am

Boehringer Ingelheim

non-small cell lung cancer

Lung Cancer Genomic Mapping Yields New Targets, Researchers Say

Bloomberg

Mon, 09/10/12 - 10:43 am

genomic mapping

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

Motley Fool

Fri, 08/31/12 - 12:27 pm

Bayer says Nexavar-Tarceva trial unsuccessful

Reuters

Mon, 07/23/12 - 08:55 am

ONYX Pharmaceuticals

Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without their disease getting worse

Pipeline Review

Sat, 06/4/11 - 11:13 am

Roche’s Tarceva Stalls Lung Cancer in Late-Stage Study

Yahoo/AP

Fri, 06/3/11 - 10:42 am

Roche Tarceva Drug's Use in Lung Cancer Predicted in Cancer Cell Genes

Bloomberg

Sun, 04/3/11 - 09:29 am

Astellas, Partners Reach Settlement With Teva on Tarceva Patent

Bloomberg

Wed, 03/16/11 - 09:17 am

Teva Pharmaceuticals

Roche’s Tarceva Extends Lives, Study Stopped Early

Bloomberg

Fri, 01/28/11 - 09:41 am

FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer

Yahoo/BusinessWire

Sat, 04/17/10 - 12:23 pm

OSI Pharmaceuticals

non-small cell lung cancer

Arqule Joins the Phase III Club

Seeking Alpha

Wed, 04/14/10 - 07:44 am

clinical trials

OSI reports European recommendation on Tarceva

Yahoo/AP

Fri, 03/19/10 - 10:23 am

OSI Pharmaceuticals

OSI CEO Goddard Rejects Astellas on Tarceva $7 Billion Promise

Bloomberg

Mon, 03/15/10 - 11:57 am

OSI Pharmaceuticals

FDA Extends Review Period for Tarceva Application for First-Line Maintenance Use in Advanced Non-Small Cell Lung Cancer

Yahoo/BusinessWire

Sat, 01/16/10 - 11:08 am

OSI Pharmaceuticals

Lilly to Benefit from OSI Rejection

Seeking Alpha

Thu, 12/17/09 - 04:00 pm

OSI Pharmaceuticals

Pages